CSIMarket
 


Nanoviricides inc   (NNVC)
Other Ticker:  
 
 

NNVC's Net Cash Flow Growth by Quarter and Year

Nanoviricides Inc 's Net Cash Flow results by quarter and year




NNVC Net Cash Flow (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter June - -1.50 -1.51 -2.38
III Quarter March - -1.80 -1.76 4.51
II Quarter December -1.72 -1.47 -2.36 -3.40
I Quarter September -1.18 -1.15 -0.82 8.08
FY   -2.90 -5.92 -6.45 6.81



NNVC Net Cash Flow second quarter 2024 Y/Y Growth Comment
Nanoviricides inc in the second quarter 2024 recorded net cash outflow of $ -1.72 millions.

According to the results reported in the second quarter 2024, Nanoviricides Inc achieved the best Net Cash Flow growth in Major Pharmaceutical Preparations industry. While Nanoviricides Inc ' s Net Cash Flow no change of % ranks overall at the positon no. in the second quarter 2024.




NNVC Net Cash Flow ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter June - - - -
III Quarter March - - - 27.04 %
II Quarter December - - - -
I Quarter September - - - -
FY   - - - -38.92 %

Financial Statements
Nanoviricides Inc 's second quarter 2024 Net Cash Flow $ -1.72 millions NNVC's Income Statement
Nanoviricides Inc 's second quarter 2023 Net Cash Flow $ -1.47 millions Quarterly NNVC's Income Statement
New: More NNVC's historic Net Cash Flow Growth >>


NNVC Net Cash Flow (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter June - - - -
III Quarter March - - - -
II Quarter December - - - -
I Quarter September - - - 6.32 %
FY (Year on Year)   - - - -38.92 %




Net Cash Flow second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Cash Flow second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Cash Flow by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Nanoviricides Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NNVC's II. Quarter Q/Q Net Cash Flow Comment
Current accomplishment of -1.72 millions by Nanoviricides inc come out even worse considering the -1.18 millions net cash outflow a quarter before.

Within Major Pharmaceutical Preparations industry Nanoviricides inc achieved highest sequential Net Cash Flow growth. While Nanoviricides Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NNVC's II. Quarter Q/Q Net Cash Flow Comment
Current results of -1.72 millions by Nanoviricides inc look even more unfavourable if you take a look at -1.18 millions net cash outflow a quarter before.

Within Major Pharmaceutical Preparations industry Nanoviricides inc achieved highest sequential Net Cash Flow growth. While Nanoviricides Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Nanoviricides Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Net Cash Flow 12 Months Ending $ -6.20 $ -5.95 $ -5.92 $ -5.92 $ -5.89
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) - - - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Net Cash Flow growth Comment
Nanoviricides Inc ' has realized cumulative trailing twelve months net cash outflow of $ -6 millions in the Dec 31 2023 period.
The business is getting worse as the cumulative net cash outflow is getting bigger from $ -5.95 millions for the period from Sep 30 2023 to Dec 31 2022 and $ -6.77875 millions for the twelve months ending in the quarter a year ago.

Nanoviricides inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Cash Flow growth Comment
Nanoviricides Inc ' has realized cumulative trailing twelve months net cash outflow of $ -6 millions in the Dec 31 2023 period.
The results are worsening as the cumulative net cash outflow is getting bigger from $ -5.95 millions for the period from Sep 30 2023 to Dec 31 2022 and $ -6.77875 millions for the twelve months ending in the quarter Dec 31 2022.

Nanoviricides inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Cash Flow Growth
Major Pharmaceutical Preparations Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
NNVC's Net Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for NNVC's Competitors
Net Cash Flow Growth for Nanoviricides Inc 's Suppliers
Net Cash Flow Growth for NNVC's Customers

You may also want to know
NNVC's Annual Growth Rates NNVC's Profitability Ratios NNVC's Asset Turnover Ratio NNVC's Dividend Growth
NNVC's Roe NNVC's Valuation Ratios NNVC's Financial Strength Ratios NNVC's Dividend Payout Ratio
NNVC's Roa NNVC's Inventory Turnover Ratio NNVC's Growth Rates NNVC's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Dec 31 2023
Celldex Therapeutics inc 26.13%$ 26.129 millions
Sanofi26.12%$ 26.124 millions
Molecular Partners Ag22.47%$ 22.465 millions
Diamedica Therapeutics Inc 18.09%$ 18.089 millions
Bionomics Limited17.77%$ 17.774 millions
Perrigo Company Plc15.91%$ 15.909 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com